74-year-old man with stage T2a Gleason score 3 + 4 prostate cancer (prostate specific antigen = 14.56 ng/mL) in right transition zone (TZ) with history.

Slides:

Advertisements

Similar presentations

Diffusion-Weighted Imaging in Magnetic Resonance Imaging for prostate gland in Malaysian males with high prostate specific antigen in the diagnosis of.

Advertisements

Prostate Cancer Genetics and Diagnosis

In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparison of MR/Ultrasound Fusion–Guided Biopsy With.

Focal Magnetic Resonance Guided Intensity Focused Ultrasound Treatment of Low Risk Prostate Cancer: A Phase I Trial. Alexandr Nosov, Sergey Kanaev, Georg.

Fig. 2. Computed tomography (CT) and magnetic resonance images of 34-year-old man with right nasal tumor diagnosed as cavernous hemangioma. A. Early-phase.

Fig. 2. Imaging findings of the lesion on brain MRI

Fig. 9. Warthin's tumor, a 72-year-old man with supraglottic cancer. A

Fig. 16. A 56-year-old woman, who was diagnosed ovarian cancer with metastatic cancer in left axilla, underwent breast MRI. (a, b) On axial T2 and T1 weighted.

Fig. 3. Gadoxetic acid-enhanced MRI in 69-year-old man with chronic hepatitis C.On arterial phase (A), 1.2 cm enhancing nodule is seen in S8 (arrows),

Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer

Don Nguyen1, Sean Li1, Jinxing Yu, MD1

Fig year-old man with CLL and transformation to DLBCL. A

Fig year-old woman with invasive lobular breast cancer. A

Fig. 7. A 70-year-old woman with invasive lobular cancer involving right breast underwent breast MRI. (a, b) On axial breast MRI, segmental clumped nonmass.

Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old.

Fig. 1. Luminal A type breast cancer of 37-year-old woman. A

Fig. 2. Triple negative type breast cancer of 37-year-old woman. A

Prostate cancer นพ.ชัชชัย หอมเกตุ.

Fig. 2. A 36-year-old woman underwent right breast-conserving surgery due to invasive ductal cancer seven months prior. A mediolateral oblique mammography.

Fig. 1. Screening breast MR images of 31-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as negative finding.

Fig. 21. Adenocarcinoma.Circumferential wall thickening of duodenum is detected on axial fast spin echo T2-weighted image (arrow in A) in 73-year-old patient.

Fig. 17. A 54-year-old male with recent voice change. A

Fig year-old man with lymph-node metastasis from pelvic extraskeletal Ewing sarcoma family of tumors. A. Axial contrast-enhanced computed tomography.

Fig. 5. A 13-year-old boy with epidermoid cyst of the skull

Fig FDG PET-CT and diagnostic contrast-enhanced chest CT in patient with angioimmunoblastic T-cell lymphoma. MIP image (A) demonstrates intense 18FDG.

Fig. 3. Fig. 3. Triple arterial phase of 70-year-old woman with colon cancer liver metastasis.1st scan was deteriorated by significant motion artifacts.

Fig. 1. T2* relaxation time mapping from 55-year-old woman with ductal carcinoma in situ. A. Sagittal contrast-enhanced T1-weighted image shows heterogeneous.

Fig year-old woman with dedifferentiated retroperitoneal liposarcoma

Fig. 4. 55-year-old man with perforated diverticulitis at the cecum with fecal peritonitis. Contrast-enhanced coronal CT image shows spillage of feces.

Fig. 2. Screening breast MR images of 46-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as multiple benign.

Fig. 3.Lumbosacral spine magnetic resonance imaging (MRI) of 48-year-old woman who presented with low back pain. A. Sagittal T2-weighted image shows asymmetric.

Fig year-old male with left shoulder weakness after radiation therapy for metastatic lymph nodes in left supraclavicular area due to right lung.

Volume 70, Issue 5, Pages (November 2016)

Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging:

Volume 67, Issue 3, Pages (March 2015)

European Urology Oncology

Dynamic Contrast-Enhanced MRI for Preoperative Identification of Localised Prostate Cancer Arnauld Villers, Philippe Puech, Xavier Leroy, Jacques Biserte,

Volume 72, Issue 3, Pages (September 2017)

Volume 66, Issue 1, Pages (July 2014)

Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI- RADS v2) scoring system in diagnosis of peripheral zone prostate cancer

Prostate MRI: The Hemorrhage Exclusion Sign

Volume 62, Issue 1, Pages (July 2012)

Fig. 3. Sub-centimeter-sized HCC in 56-year-old man with chronic hepatitis B. Gadoxetic acid-enhanced MR image demonstrates 0.8-cm nodule (arrows) in right.

Volume 62, Issue 6, Pages (December 2012)

Volume 67, Issue 4, Pages (April 2015)

Volume 59, Issue 6, Pages (June 2011)

Tillmann Loch, Pat Fox Fulgham European Urology

Volume 65, Issue 4, Pages (April 2014)

Magnetic Resonance Imaging–Guided Vacuum-Assisted Breast Biopsy: An Initial Experience in a Community Hospital Paul Friedman, DO, Sean Enis, MD, Jeremy.

Nandita M. deSouza, Veronica A. Morgan, Elizabeth Bancroft, S

Volume 69, Issue 1, Pages (January 2016)

Fig year-old male with brain metastases from lung cancer

Fig year-old woman with invasive ductal carcinoma of right breast

Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes Following irreversible electroporation (IRE)

ABUS = automated breast ultrasonography

Fig. 6. Hepatocellular carcinoma showing irregular rim enhancement

C. In the hepatobiliary phase, the lesion shows hypointensity (arrow).

C. T2WI shows a hyperintense mass and T1WI shows a hypointense mass.

Posterior sternoclavicular dislocation in 16-year-old man. A

Fig. 1. Axial CT images in 78-year-old man with history of esophageal cancer.A. Contrast-enhanced chest CT image shows 1.3-cm solid nodule in right upper.

Fig. 5. Measurement of extramural depth of tumor invasion in T3 rectal cancer. A. MRI measurements on axial (left) and coronal (right) views are 6.1 and.

Fig. 2. Axial CT images in 21-year-old man diagnosed with acquired immunodeficiency syndrome.He was referred for incidentally detected pulmonary mass during.

Fig. 3. Representative false-positive cases. A

Fig. 9. A 56-year-old woman, who underwent chemotherapy due to advanced gastric cancer, complained of swelling and erythema of left breast. She underwent.

Fig year-old woman with newly diagnosed inflammatory breast cancer. A-C. Axial fused PET-CT images of supraclavicular region, upper and mid chest.

Fig day-old female with hypoglycemic encephalopathy

Fig. 2. (a) Three dimensional MRCP shows mild displacement of the CBD (arrows). The right posterior intrahepatic duct (arrowhead) drains at the mid CBD.

Images from a 62-year-old male patient presenting with a heterogeneous mass in the superior lobe of the right lung. a) Fusion of axial fat-saturated T1-weighted.

Single-site disease progression after 9 months of response to therapy in the right hemipelvis visualized by diffusion-weighted whole-body MRI. Top, fusion.

Presentation transcript:

74-year-old man with stage T2a Gleason score 3 + 4 prostate cancer (prostate specific antigen = 14.56 ng/mL) in right transition zone (TZ) with history of one previous negative transrectal ultrasound-guided biopsy underwent subsequent multiparametric MRI for clinical suspicion of prostate cancer. A-D. Axial color-coded wash-in/wash-out image (A) and dynamic contrast-enhanced (D) images show asymmetric increased enhancement (cross) in right TZ. This mass demonstrates focal low signal intensity (cross) on axial apparent diffusion coefficient map (B) and T2-weighted (C) images. E. Oblique axial T2-weighted image confirms needle position (arrow) in right TZ. In this MRI-guided biopsy specimen, Gleason score 3 + 4 prostate cancer was found. Fig. 3. 74-year-old man with stage T2a Gleason score 3 + 4 prostate cancer (prostate specific antigen = 14.56 ng/mL) in right transition zone (TZ) with history of one previous negative transrectal ultrasound-guided biopsy underwent subsequent multiparametric MRI for clinical suspicion of prostate cancer. A-D. Axial color-coded wash-in/wash-out image (A) and . . . Korean J Radiol. 2015 Jan-Feb;16(1):90-98. http://dx.doi.org/10.3348/kjr.2015.16.1.90